Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia
- PMID: 11454539
Item in Clipboard
Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia
Haematologica.
2001 Jul.
No abstract available
Similar articles
-
Thalidomide therapy for myelofibrosis with myeloid metaplasia.Cancer. 2006 May 1;106(9):1974-84. doi: 10.1002/cncr.21827. Cancer. 2006. PMID: 16583431 Clinical Trial.
-
Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.Leuk Lymphoma. 2004 Dec;45(12):2373-86. doi: 10.1080/10428190400003267. Leuk Lymphoma. 2004. PMID: 15621750 Review.
-
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.Leukemia. 2002 Sep;16(9):1609-14. doi: 10.1038/sj.leu.2402596. Leukemia. 2002. PMID: 12200671
-
Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly.Haematologica. 2007 Feb;92(2):e15-6. doi: 10.3324/haematol.10684. Haematologica. 2007. PMID: 17405746
-
Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.Semin Hematol. 2003 Jan;40(1 Suppl 1):18-21. doi: 10.1053/shem.2003.50029. Semin Hematol. 2003. PMID: 12682877 Review.
Cited by
-
The therapy of myelofibrosis: targeting pathogenesis.Int J Hematol. 2002 Aug;76 Suppl 2:296-304. doi: 10.1007/BF03165138. Int J Hematol. 2002. PMID: 12430941 Review.
-
Profile of pomalidomide and its potential in the treatment of myelofibrosis.Ther Clin Risk Manag. 2015 Apr 2;11:549-56. doi: 10.2147/TCRM.S69211. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 25897239 Free PMC article. Review.
-
Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019.Hematol Transfus Cell Ther. 2019 Jul;41 Suppl 1(Suppl 1):1-73. doi: 10.1016/j.htct.2019.03.001. Epub 2019 May 10. Hematol Transfus Cell Ther. 2019. PMID: 31248788 Free PMC article. No abstract available.
-
Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disorders.Int J Hematol. 2002 Aug;76 Suppl 2:193-203. doi: 10.1007/BF03165117. Int J Hematol. 2002. PMID: 12430925 Review.